FCM
Farallon Capital Management Portfolio holdings
AUM
$21.3B
This Quarter Return
+10.36%
1 Year Return
+23.12%
3 Year Return
+87.19%
5 Year Return
+183.94%
10 Year Return
+836.54%
AUM
$21.3B
AUM Growth
+$21.3B
(+19%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
9.16%
Top 10 Holdings %
Top 10 Hldgs %
45.78%
Holding
160
New
16
Increased
36
Reduced
30
Closed
18
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
$3.4B |
| 2 |
Amazon
AMZN
|
$666M |
| 3 |
Aon
AON
|
$223M |
| 4 |
Thermo Fisher Scientific
TMO
|
$141M |
| 5 |
AZEK
The AZEK Co
AZEK
|
$109M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
$816M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$403M |
| 3 |
Exelixis
EXEL
|
$286M |
| 4 |
Microsoft
MSFT
|
$268M |
| 5 |
Intuit
INTU
|
$239M |
Sector Composition
| 1 | Healthcare | 34.23% |
| 2 | Technology | 14.54% |
| 3 | Financials | 10.03% |
| 4 | Communication Services | 6.05% |
| 5 | Industrials | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BridgeBio Pharma
BBIO
$9.89B
| $341M | 1.47% | 7,900,000 +2,169,000 | +38% | +$93.7M |
|
27
New York Times
NYT
$9.74B
| $314M | 1.35% | 5,609,546 -3,322,567 | -37% | -$186M |
|
28
Alphabet (Google) Class C
GOOG
$2.58T
| $313M | 1.35% | 1,761,840 +95,800 | +6% | +$17M |
|
29
Analog Devices
ADI
$124B
| $303M | 1.31% | 1,272,200 -54,800 | -4% | -$13M |
|
30
CBRE Group
CBRE
$48.2B
| $296M | 1.28% | 2,113,138 -382,562 | -15% | -$53.6M |
|
31
Wabtec
WAB
$33.1B
| $274M | 1.18% | 1,308,198 -299,900 | -19% | -$62.8M |
|
32
McKesson
MCK
$85.4B
| $231M | 0.99% | 314,600 -237,900 | -43% | -$174M |
|
33
Woodward
WWD
$14.8B
| $224M | 0.97% | 914,673 -505,027 | -36% | -$124M |
|
34
Agios Pharmaceuticals
AGIO
$2.19B
| $192M | 0.83% | 5,767,466 +67,000 | +1% | +$2.23M |
|
|
VRNA
35
Verona Pharma
VRNA
$9.16B
| $171M | 0.74% | 1,810,000 +725,011 | +67% | +$68.6M |
|
|
AZEK
36
DELISTED
The AZEK Co
AZEK
| $171M | 0.74% | 3,141,400 +2,001,400 | +176% | +$109M |
|
37
Beam Therapeutics
BEAM
$1.66B
| $170M | 0.73% | 10,013,111 +85,000 | +0.9% | +$1.45M |
|
38
Crinetics Pharmaceuticals
CRNX
$2.92B
| $134M | 0.58% | 4,646,098 +41,000 | +0.9% | +$1.18M |
|
39
Visa
V
$683B
| $110M | 0.47% | 308,810 -165,400 | -35% | -$58.7M |
|
|
CHX
40
DELISTED
ChampionX
CHX
| $105M | 0.45% | 4,245,000 +1,340,000 | +46% | +$33.3M |
|
41
GE HealthCare
GEHC
$33.7B
| $97.9M | 0.42% | 1,322,000 +785,000 | +146% | +$58.1M |
|
42
Tenet Healthcare
THC
$16.3B
| $93.1M | 0.4% | +529,000 | New | +$93.1M |
|
43
Encompass Health
EHC
$12.3B
| $86.8M | 0.37% | 708,000 +89,000 | +14% | +$10.9M |
|
44
Mastercard
MA
$538B
| $85.5M | 0.37% | 152,071 -49,300 | -24% | -$27.7M |
|
45
Cardinal Health
CAH
$35.5B
| $76.3M | 0.33% | 454,000 +181,000 | +66% | +$30.4M |
|
46
New Oriental
EDU
$7.85B
| $62.3M | 0.27% | 1,155,150 -150,000 | -11% | -$8.09M |
|
|
BBNX
47
Beta Bionics, Inc. Common Stock
BBNX
$819M
| $61.2M | 0.26% | 4,203,920 +871,700 | +26% | +$12.7M |
|
|
CNTA
48
Centessa Pharmaceuticals
CNTA
$2.25B
| $59.5M | 0.26% | 4,529,318 +195,000 | +4% | +$2.56M |
|
49
Liquidia Corp
LQDA
$2.38B
| $52.8M | 0.23% | 4,238,762 +247,806 | +6% | +$3.09M |
|
50
Flutter Entertainment
FLUT
$54B
| $51.8M | 0.22% | 181,229 -60,238 | -25% | -$17.2M |
|